Fig. 6
![Fig. 6](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13071-015-1022-z/MediaObjects/13071_2015_1022_Fig6_HTML.gif)
SmKI-1 prolongs both APTT and PT in clot formation. The normal time periods for clot formation during APTT and PT are shown by the rectangles. Aprotinin and FVII-deficient plasma were used as positive controls for APTT and PT, respectively. Error bars represent the mean ± SEM